Almaden Minerals Ltd. (USA)  

(Public, NYSEMKT:AAU)   Watch this stock  
Find more results for NYSEAMEX:AAU
1.37
+0.08 (6.20%)
Real-time:   12:32PM EDT
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.32 - 1.44
52 week 1.01 - 2.10
Open 1.34
Vol / Avg. 110,622.00/161,140.00
Mkt cap 88.37M
P/E     -
Div/yield     -
EPS -0.13
Shares 64.50M
Beta 0.57
Inst. own 5%
Feb 8, 2014
Almaden Minerals Ltd at Cambridge House International Inc California Investment Conference
Jan 19, 2014
Almaden Minerals Ltd at Cambridge House International Inc's Vancouver Resource Investment Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -1713.37% -3422.26%
Operating margin -1630.06% -3290.17%
EBITD margin - -1467.90%
Return on average assets -7.37% -19.87%
Return on average equity -7.46% -20.19%
CDP Score - -

Address

Suite 1103, 750 West Pender St.
VANCOUVER, BC V6C 2T8
Canada
+1-604-6897644 (Phone)
+1-604-6897645 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Almaden Minerals Ltd. (Almaden) is an exploration-stage company. Almaden is engaged in the business of the acquisition, exploration and when warranted, development of mineral properties. The Company has property interests in Canada, United States and Mexico. As of December 31, 2011, none of the Company's property interests are beyond exploration stage. The Company has two primary property interests: the Tuligtic prospect (100% interest) which includes the Ixtaca zone in Mexico, and the El Cobre copper-gold prospect (100% interest). The Company's non-principal interests include the ATW diamond prospect in Canada. In July 2011, the Company completed the sale of the Elk Gold Project to Gold Mountain Mining Corporation subject to a 2% net smelter return royalty (NSR). In October 2011, the Company completed the sale of its 30% interest in the Caballo Blanco project to Goldgroup Mining Inc. subject to a 1.5% NSR.

Officers and directors

James Duane Poliquin Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Morgan J. Poliquin Ph.D. President, Chief Executive Officer, Director
Age: 41
Bio & Compensation  - Reuters
Korm Trieu Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Dione Bitzer Controller, Secretary
Bio & Compensation  - Reuters
William J. Worrall Director
Bio & Compensation  - Reuters
Mark Thomas Brown CA Independent Director
Age: 44
Bio & Compensation  - Reuters
Gerald G. Carlson Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters
John D. McCleary Independent Director
Age: 72
Bio & Compensation  - Reuters
Joseph H. Montgomery Ph.D. Independent Director
Age: 86
Bio & Compensation  - Reuters